nerlynx: reducing recurrence of her2 breast cancer
Published 6 years ago • 1.5K plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
47:45
reduce the risk of recurrence with nerlynx | webinar on therapeutic decision-making
-
5:14
why worry about early-stage her2 breast cancer recurrence?
-
1:01
are you worried about her2 breast cancer recurrence?
-
1:38
breast cancer: fighting fear of recurrence
-
6:44
reducing your risk with nerlynx
-
4:49
sherry h takes a stand against early-stage her2 breast cancer recurrence with nerlynx
-
4:56
erin b takes a stand against early-stage her2 breast cancer recurrence with nerlynx
-
5:30
early-stage her2 breast cancer: become an advocate in your care with nerlynx
-
5:23
what support is available with nerlynx for early-stage her2 breast cancer treatment?
-
6:16
why sherry decided on nerlynx for early-stage her2 breast cancer treatment
-
5:56
where does nerlynx fit into treatment for early-stage her2 breast cancer?
-
2:13
n9831 trial: genes associated with early and late recurrence in her2 breast cancer
-
0:45
the evolution of her2-low breast cancer from primary to recurrence
-
2:25
reducing risk in residual breast cancer
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
2:18
use of neratinib in her2-positive breast cancer
-
3:22
managing recurrent metastatic er /her2- breast cancer